Biotechnology
The Biotechnology industry has a total of 610 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.25 billion.
Market Cap
1.11T
Revenue
105.25B
Profits
-42.74B
PE Ratio
n/a
Profit Margin
-40.61%
Dividend Yield
0.04%
610 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.05B | 1.37% | 1,550,242 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.78B | 3.40% | 1,200,573 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 56.78B | -1.02% | 1,009,228 | 3.21B |
| 4 | ARGX | argenx SE | 55.58B | 1.23% | 380,744 | 3.68B |
| 5 | INSM | Insmed Incorporated | 44.58B | 1.01% | 2,196,814 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 37.09B | 0.74% | 369,089 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.98B | 3.28% | 1,212,314 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.82B | -0.53% | 7,167,532 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.72B | -0.65% | 1,701,879 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.10B | 1.88% | 1,189,865 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 14.75B | 3.61% | 2,051,288 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.51B | 2.76% | 7,676,372 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.61B | -0.51% | 1,877,075 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.60B | -1.12% | 1,780,807 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.45B | 0.70% | 359,795 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.11B | 3.07% | 2,543,172 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.63B | -1.14% | 468,971 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.61B | 2.08% | 2,885,593 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.94B | -0.47% | 1,127,498 | 4.16B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 1.42% | 2,544,620 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.78B | 0.49% | 2,523,598 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.26B | 3.72% | 2,046,999 | 1.22B |
| 23 | MRNA | Moderna, Inc. | 9.67B | 2.48% | 6,713,200 | 2.23B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.48B | 2.00% | 917,889 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.56B | -1.59% | 2,421,630 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.44B | 3.31% | 545,143 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 8.26B | 0.51% | 2,112,949 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.99B | 0.30% | 828,898 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.58B | -0.56% | 359,541 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.28B | 0.08% | 1,681,304 | 56.61M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.26B | 2.04% | 613,621 | 174.33M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.22B | 1.71% | 1,410,644 | 649.06M |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.91B | -0.27% | 726,881 | 302.00K |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.66B | 3.88% | 4,288,524 | 1.78B |
| 35 | PCVX | Vaxcyte, Inc. | 6.58B | 2.01% | 1,078,348 | - |
| 36 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.47B | 5.72% | 2,951,032 | 829.45M |
| 37 | KRYS | Krystal Biotech, Inc. | 6.29B | 0.97% | 196,965 | 373.16M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.04B | 3.06% | 3,110,478 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.62B | 2.47% | 911,005 | 209.22M |
| 40 | LEGN | Legend Biotech Corporation | 5.21B | 3.83% | 2,445,261 | 909.05M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.11B | 4.53% | 2,359,109 | 38.34M |
| 42 | TGTX | TG Therapeutics, Inc. | 4.82B | 2.97% | 1,818,331 | 531.90M |
| 43 | APGE | Apogee Therapeutics, Inc. | 4.79B | 4.52% | 751,070 | - |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.75B | 0.69% | 675,802 | 43.74M |
| 45 | PRAX | Praxis Precision Medicines, Inc. | 4.61B | -3.46% | 1,097,970 | 7.46M |
| 46 | NAMS | NewAmsterdam Pharma Company N.V. | 4.59B | 2.87% | 964,771 | 35.24M |
| 47 | CELC | Celcuity Inc. | 4.58B | -2.05% | 930,744 | - |
| 48 | ADMA | ADMA Biologics, Inc. | 4.57B | 4.86% | 3,748,960 | 488.56M |
| 49 | AKRO | Akero Therapeutics, Inc. | 4.48B | - | 715,007 | - |
| 50 | BLTE | Belite Bio, Inc | 4.46B | -6.03% | 537,901 | - |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.24B | 1.98% | 1,162,770 | 1.54M |
| 52 | CNTA | Centessa Pharmaceuticals plc | 4.23B | -1.40% | 2,061,027 | 15.00M |
| 53 | SRRK | Scholar Rock Holding Corporation | 4.23B | -0.77% | 2,103,174 | - |
| 54 | ACLX | Arcellx, Inc. | 4.22B | -2.61% | 2,416,664 | 35.90M |
| 55 | IMVT | Immunovant, Inc. | 4.20B | 2.70% | 1,578,272 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.13B | 2.05% | 1,143,446 | 1.05B |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.01B | 2.34% | 2,234,811 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.76B | -0.10% | 1,707,759 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.69B | -0.61% | 324,203 | 471.79M |
| 60 | CGON | CG Oncology, Inc. | 3.67B | 4.48% | 724,623 | 2.17M |
| 61 | IRON | Disc Medicine, Inc. | 3.49B | -1.68% | 535,277 | - |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | 4.49% | 1,231,073 | 7.50M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.35B | -3.93% | 739,892 | 366.10M |
| 64 | MLYS | Mineralys Therapeutics, Inc. | 3.34B | -0.94% | 1,658,405 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.24B | 5.13% | 61,528 | 664.23M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.23B | 2.27% | 1,514,105 | 630.60M |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.22B | 0.61% | 1,320,636 | 435.83M |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.11B | 2.37% | 1,070,400 | 214.83M |
| 69 | ADPT | Adaptive Biotechnologies Corporation | 3.10B | -0.68% | 2,739,365 | 252.75M |
| 70 | FOLD | Amicus Therapeutics, Inc. | 3.05B | -0.20% | 4,054,999 | 598.70M |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.00B | 4.75% | 3,416,775 | 240.00M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 3.00B | -1.94% | 2,303,765 | 70.79M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.97B | -4.01% | 2,570,117 | - |
| 74 | AAPG | Ascentage Pharma Group International | 2.96B | 1.06% | 593 | 54.52M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | 0.34% | 1,818,490 | 578.20M |
| 76 | LQDA | Liquidia Corporation | 2.81B | 8.00% | 2,201,912 | 69.22M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.81B | 1.06% | 1,284,884 | - |
| 78 | NUVB | Nuvation Bio Inc. | 2.70B | 6.34% | 7,724,687 | 26.75M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.67B | 8.41% | 2,633,888 | 98.68M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.66B | 4.32% | 2,302,210 | 1.02B |
| 81 | TERN | Terns Pharmaceuticals, Inc. | 2.64B | 4.65% | 4,345,524 | - |
| 82 | OCUL | Ocular Therapeutix, Inc. | 2.58B | 0.25% | 2,284,232 | 55.78M |
| 83 | EWTX | Edgewise Therapeutics, Inc. | 2.55B | 2.47% | 1,743,041 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.44B | 4.53% | 3,625,202 | 55.70M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.28B | 0.92% | 16,238,776 | 43.69M |
| 86 | SYRE | Spyre Therapeutics, Inc. | 2.26B | 8.21% | 630,512 | - |
| 87 | MESO | Mesoblast Limited | 2.25B | 2.82% | 213,532 | 17.20M |
| 88 | ZLAB | Zai Lab Limited | 2.20B | -0.15% | 555,926 | 441.63M |
| 89 | VCEL | Vericel Corporation | 2.15B | 9.41% | 1,048,958 | 258.72M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | 1.06% | 1,399,065 | 265.81M |
| 91 | ZBIO | Zenas BioPharma, Inc. | 2.14B | 4.21% | 326,444 | 15.00M |
| 92 | JANX | Janux Therapeutics, Inc. | 2.09B | 10.18% | 2,531,669 | 10.00M |
| 93 | GPCR | Structure Therapeutics Inc. | 2.07B | -3.20% | 1,768,243 | - |
| 94 | IBRX | ImmunityBio, Inc. | 2.05B | -3.26% | 7,280,745 | 82.56M |
| 95 | GLPG | Galapagos NV | 2.04B | 0.23% | 84,978 | 336.64M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | 0.20% | 916,595 | 825.94M |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 2.03B | 2.33% | 3,000,137 | 2.41B |
| 98 | IMCR | Immunocore Holdings plc | 2.01B | 3.05% | 700,344 | 379.59M |
| 99 | SION | Sionna Therapeutics, Inc. | 1.97B | -0.38% | 236,013 | - |
| 100 | ZYME | Zymeworks Inc. | 1.96B | 4.76% | 1,638,455 | 134.48M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.89B | 0.94% | 719,196 | 3.08M |
| 102 | VERA | Vera Therapeutics, Inc. | 1.88B | 0.65% | 1,578,154 | - |
| 103 | OLMA | Olema Pharmaceuticals, Inc. | 1.79B | 4.07% | 3,780,769 | - |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.76B | 0.03% | 276,286 | 2.50M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.76B | 0.46% | 408,540 | 2.60M |
| 106 | QURE | uniQure N.V. | 1.74B | 0.65% | 1,920,172 | 15.75M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -0.87% | 1,126,790 | 83.69M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.70B | -1.71% | 2,335,148 | 205.63M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -1.57% | 2,767,844 | 111.30M |
| 110 | IMNM | Immunome, Inc. | 1.68B | -1.88% | 842,955 | 9.68M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 7.30% | 2,298,052 | 44.79M |
| 112 | PHVS | Pharvaris N.V. | 1.65B | 0.24% | 269,556 | - |
| 113 | MNKD | MannKind Corporation | 1.65B | 4.48% | 2,503,488 | 313.79M |
| 114 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.63B | 0.40% | 896,117 | -665.00K |
| 115 | INVA | Innoviva, Inc. | 1.62B | 2.02% | 797,916 | 388.52M |
| 116 | UPB | Upstream Bio, Inc. | 1.56B | 10.67% | 683,358 | 2.80M |
| 117 | ORKA | Oruka Therapeutics, Inc. | 1.48B | 2.18% | 384,419 | - |
| 118 | TRVI | Trevi Therapeutics, Inc. | 1.46B | -0.44% | 1,266,298 | - |
| 119 | TNGX | Tango Therapeutics, Inc. | 1.42B | 2.32% | 2,483,766 | 66.50M |
| 120 | MBX | MBX Biosciences, Inc. | 1.42B | 1.15% | 683,499 | - |
| 121 | RLAY | Relay Therapeutics, Inc. | 1.40B | -1.47% | 2,122,619 | 8.36M |
| 122 | ARDX | Ardelyx, Inc. | 1.39B | 4.00% | 2,856,460 | 398.23M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.36B | 0.92% | 358,479 | - |
| 124 | IMTX | Immatics N.V. | 1.33B | 3.49% | 550,097 | 99.45M |
| 125 | PGEN | Precigen, Inc. | 1.30B | -3.93% | 2,755,434 | 6.31M |
| 126 | URGN | UroGen Pharma Ltd. | 1.30B | 2.82% | 652,962 | 96.52M |
| 127 | ELVN | Enliven Therapeutics, Inc. | 1.29B | -0.32% | 950,569 | - |
| 128 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 3.85% | 3,449,239 | 6.31M |
| 129 | SEPN | Septerna, Inc. | 1.25B | -1.89% | 360,570 | 22.05M |
| 130 | BHVN | Biohaven Ltd. | 1.25B | -2.79% | 2,634,772 | - |
| 131 | SVRA | Savara Inc. | 1.24B | -1.15% | 2,062,793 | - |
| 132 | WVE | Wave Life Sciences Ltd. | 1.24B | -0.40% | 1,485,474 | 109.23M |
| 133 | XNCR | Xencor, Inc. | 1.23B | 3.11% | 813,210 | 150.13M |
| 134 | NKTR | Nektar Therapeutics | 1.23B | 2.92% | 502,872 | 62.60M |
| 135 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.22B | 2.36% | 805,705 | 42.34M |
| 136 | KOD | Kodiak Sciences Inc. | 1.22B | 5.12% | 812,434 | - |
| 137 | INBX | Inhibrx Biosciences, Inc. | 1.20B | 2.06% | 202,433 | 1.40M |
| 138 | CVAC | CureVac N.V. | 1.19B | 3.33% | 1,922,563 | 83.00M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.18B | 6.95% | 1,654,128 | 2.76B |
| 140 | XERS | Xeris Biopharma Holdings, Inc. | 1.18B | 0.85% | 1,339,071 | 266.14M |
| 141 | PHAR | Pharming Group N.V. | 1.17B | -0.37% | 5,116 | 362.27M |
| 142 | MNMD | Mind Medicine (MindMed) Inc. | 1.17B | 1.11% | 1,397,726 | - |
| 143 | TYRA | Tyra Biosciences, Inc. | 1.17B | -1.62% | 537,443 | - |
| 144 | ANAB | AnaptysBio, Inc. | 1.15B | -1.10% | 380,565 | 169.47M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -1.44% | 1,087,644 | - |
| 146 | PVLA | Palvella Therapeutics, Inc. | 1.12B | -3.22% | 285,112 | - |
| 147 | OCS | Oculis Holding AG | 1.12B | 0.21% | 122,814 | 992.00K |
| 148 | NVAX | Novavax, Inc. | 1.09B | 0.90% | 2,553,537 | 1.06B |
| 149 | ABCL | AbCellera Biologics Inc. | 1.08B | 1.40% | 3,655,400 | 35.33M |
| 150 | GLUE | Monte Rosa Therapeutics, Inc. | 1.04B | 1.65% | 960,144 | 181.54M |
| 151 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 0.74% | 501,605 | 147.19M |
| 152 | MDXG | MiMedx Group, Inc. | 1.03B | 2.51% | 562,323 | 393.44M |
| 153 | BCAX | Bicara Therapeutics Inc. | 1.01B | -2.22% | 1,141,343 | - |
| 154 | KURA | Kura Oncology, Inc. | 1.01B | -1.11% | 1,534,537 | 104.03M |
| 155 | NBTX | Nanobiotix S.A. | 1.01B | -3.50% | 68,121 | 11.93M |
| 156 | NTLA | Intellia Therapeutics, Inc. | 990.35M | 2.40% | 4,110,944 | 57.53M |
| 157 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 988.66M | 0.57% | 97,424 | - |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 984.48M | -0.80% | 9,520,003 | 250.43M |
| 159 | MLTX | MoonLake Immunotherapeutics | 971.39M | 3.50% | 2,463,927 | - |
| 160 | DAWN | Day One Biopharmaceuticals, Inc. | 968.23M | 6.19% | 2,819,335 | 133.67M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 961.46M | 2.17% | 1,186,537 | 192.44M |
| 162 | TBPH | Theravance Biopharma, Inc. | 959.74M | 2.38% | 852,730 | 80.33M |
| 163 | AVBP | ArriVent BioPharma, Inc. | 940.39M | 5.90% | 368,286 | - |
| 164 | SANA | Sana Biotechnology, Inc. | 934.95M | -0.85% | 3,974,999 | - |
| 165 | LENZ | LENZ Therapeutics, Inc. | 934.94M | -6.45% | 656,070 | 17.50M |
| 166 | GHRS | GH Research PLC | 923.93M | 2.16% | 517,131 | - |
| 167 | SPRY | ARS Pharmaceuticals, Inc. | 917.32M | 15.57% | 3,861,132 | 142.77M |
| 168 | RIGL | Rigel Pharmaceuticals, Inc. | 899.58M | -0.48% | 715,577 | 282.08M |
| 169 | VIR | Vir Biotechnology, Inc. | 895.97M | 5.23% | 2,646,588 | 16.86M |
| 170 | CMPX | Compass Therapeutics, Inc. | 891.09M | 1.21% | 2,714,550 | 850.00K |
| 171 | RZLT | Rezolute, Inc. | 883.69M | -2.46% | 1,680,331 | - |
| 172 | ERAS | Erasca, Inc. | 871.00M | 6.23% | 3,048,015 | - |
| 173 | ABUS | Arbutus Biopharma Corporation | 830.84M | 1.17% | 555,076 | 14.61M |
| 174 | RAPT | RAPT Therapeutics, Inc. | 830.49M | 2.92% | 518,078 | - |
| 175 | ATAI | Atai Beckley N.V. | 805.91M | -2.08% | 2,912,085 | 3.02M |
| 176 | VSTM | Verastem, Inc. | 791.11M | 4.17% | 1,820,154 | 13.38M |
| 177 | ARVN | Arvinas, Inc. | 778.40M | 2.97% | 1,240,478 | 312.30M |
| 178 | ALMS | Alumis Inc. | 765.20M | 0.41% | 797,485 | 22.12M |
| 179 | GOSS | Gossamer Bio, Inc. | 756.86M | 2.83% | 2,388,484 | 44.05M |
| 180 | VALN | Valneva SE | 752.56M | -0.91% | 5,637 | 211.09M |
| 181 | REPL | Replimune Group, Inc. | 747.56M | 1.49% | 886,412 | - |
| 182 | VTYX | Ventyx Biosciences, Inc. | 746.41M | 5.13% | 1,112,928 | - |
| 183 | CRMD | CorMedix Inc. | 740.62M | -4.28% | 3,214,494 | 214.30M |
| 184 | GERN | Geron Corporation | 740.49M | - | 6,240,235 | 183.40M |
| 185 | LXEO | Lexeo Therapeutics, Inc. | 709.44M | -2.70% | 791,319 | - |
| 186 | ATXS | Astria Therapeutics, Inc. | 704.43M | -0.08% | 2,319,178 | 706.00K |
| 187 | CTMX | CytomX Therapeutics, Inc. | 703.16M | 4.53% | 1,654,521 | 113.63M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 701.67M | -1.91% | 42,335 | 107.27M |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 696.51M | -8.82% | 2,696,732 | - |
| 190 | RGNX | REGENXBIO Inc. | 680.88M | 9.98% | 967,355 | 161.32M |
| 191 | KALV | KalVista Pharmaceuticals, Inc. | 671.25M | -0.60% | 948,760 | 1.43M |
| 192 | OMER | Omeros Corporation | 670.01M | -3.18% | 1,307,583 | - |
| 193 | CRVS | Corvus Pharmaceuticals, Inc. | 662.43M | 3.38% | 725,958 | - |
| 194 | PRME | Prime Medicine, Inc. | 658.58M | -1.85% | 1,855,827 | 5.98M |
| 195 | YDES | YD Bio Limited | 653.27M | 5.21% | 66,014 | 510.36K |
| 196 | ANNX | Annexon, Inc. | 642.60M | -1.55% | 2,849,086 | - |
| 197 | PROK | ProKidney Corp. | 631.75M | -1.87% | 1,266,989 | 744.00K |
| 198 | FULC | Fulcrum Therapeutics, Inc. | 624.53M | -1.70% | 361,899 | 80.00M |
| 199 | FDMT | 4D Molecular Therapeutics, Inc. | 610.20M | -1.93% | 673,169 | 120.00K |
| 200 | MGTX | MeiraGTx Holdings plc | 610.12M | 0.13% | 554,190 | 27.42M |
| 201 | IVA | Inventiva S.A. | 604.48M | 9.41% | 131,214 | 19.93M |
| 202 | MNPR | Monopar Therapeutics Inc. | 591.21M | -4.61% | 138,102 | - |
| 203 | ASMB | Assembly Biosciences, Inc. | 588.87M | -1.85% | 76,800 | 37.19M |
| 204 | JBIO | Jade Biosciences, Inc. | 576.89M | 3.21% | 209,360 | - |
| 205 | PRTA | Prothena Corporation plc | 565.21M | 0.96% | 515,553 | 11.79M |
| 206 | EVMN | Evommune, Inc. | 563.95M | -3.25% | 42,460 | 3.00M |
| 207 | NAGE | Niagen Bioscience, Inc. | 563.83M | 2.62% | 1,001,013 | 124.71M |
| 208 | MPLT | MapLight Therapeutics, Inc. | 559.05M | -1.46% | 258,670 | - |
| 209 | ADCT | ADC Therapeutics SA | 543.82M | 0.46% | 525,181 | 75.21M |
| 210 | ALT | Altimmune, Inc. | 536.32M | 0.78% | 3,321,479 | 20.00K |
| 211 | DSGN | Design Therapeutics, Inc. | 536.03M | 8.91% | 343,380 | - |
| 212 | IVVD | Invivyd, Inc. | 529.19M | -5.42% | 3,575,310 | 50.04M |
| 213 | KROS | Keros Therapeutics, Inc. | 527.67M | 1.82% | 1,688,710 | 246.72M |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 512.39M | -0.70% | 1,167,910 | 70.86M |
| 215 | ENGN | enGene Holdings Inc. | 497.90M | 4.05% | 534,857 | - |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 495.04M | 1.16% | 849,362 | 180.61M |
| 217 | IMRX | Immuneering Corporation | 480.40M | -0.67% | 493,492 | - |
| 218 | LYEL | Lyell Immunopharma, Inc. | 478.05M | -0.84% | 50,873 | 41.00K |
| 219 | BCYC | Bicycle Therapeutics plc | 476.56M | 1.93% | 308,931 | 28.34M |
| 220 | DBVT | DBV Technologies S.A. | 473.91M | -3.14% | 418,640 | 5.50M |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 472.90M | -2.89% | 1,636,258 | 84.39M |
| 222 | DRUG | Bright Minds Biosciences Inc. | 471.76M | 8.37% | 91,527 | - |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 470.26M | 12.87% | 965,348 | - |
| 224 | ABSI | Absci Corporation | 461.64M | 3.72% | 3,674,654 | 2.82M |
| 225 | NBP | NovaBridge Biosciences | 449.54M | -2.74% | 902,434 | - |
| 226 | BNTC | Benitec Biopharma Inc. | 437.84M | -1.07% | 82,649 | - |
| 227 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | -0.57% | 825,712 | 10.82M |
| 228 | PEPG | PepGen Inc. | 415.93M | 4.49% | 732,833 | - |
| 229 | ANRO | Alto Neuroscience, Inc. | 415.05M | 0.45% | 198,152 | - |
| 230 | LBRX | LB Pharmaceuticals Inc | 409.85M | 0.37% | 114,977 | - |
| 231 | SLDB | Solid Biosciences Inc. | 401.24M | 4.89% | 766,149 | - |
| 232 | TECX | Tectonic Therapeutic, Inc. | 397.72M | 8.09% | 355,690 | - |
| 233 | PRTC | PureTech Health plc | 394.44M | 1.40% | 5,106 | 6.39M |
| 234 | XOMA | XOMA Royalty Corporation | 394.34M | 0.14% | 54,478 | 47.11M |
| 235 | ENTA | Enanta Pharmaceuticals, Inc. | 394.26M | 0.07% | 425,466 | 65.32M |
| 236 | AURA | Aura Biosciences, Inc. | 388.00M | 11.09% | 429,983 | - |
| 237 | TENX | Tenax Therapeutics, Inc. | 381.36M | 4.44% | 147,315 | - |
| 238 | CLLS | Cellectis S.A. | 378.19M | -2.06% | 135,775 | 82.55M |
| 239 | NMRA | Neumora Therapeutics, Inc. | 375.95M | 4.17% | 1,649,245 | - |
| 240 | AUTL | Autolus Therapeutics plc | 369.94M | 12.10% | 32,319,830 | 51.13M |
| 241 | GALT | Galectin Therapeutics Inc. | 368.14M | 3.63% | 260,239 | - |
| 242 | OCGN | Ocugen, Inc. | 365.41M | -1.68% | 1,853,830 | 5.37M |
| 243 | TRDA | Entrada Therapeutics, Inc. | 362.92M | 2.33% | 248,531 | 61.52M |
| 244 | FBRX | Forte Biosciences, Inc. | 356.45M | 4.88% | 180,299 | - |
| 245 | VTVT | vTv Therapeutics Inc. | 345.96M | -6.63% | 19,368 | 17.00K |
| 246 | AVTX | Avalo Therapeutics, Inc. | 344.36M | 5.50% | 391,184 | 192.00K |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 335.49M | 2.31% | 1,505,039 | - |
| 248 | DRTS | Alpha Tau Medical Ltd. | 332.53M | 6.85% | 102,049 | - |
| 249 | PYXS | Pyxis Oncology, Inc. | 332.49M | 3.69% | 597,496 | 2.82M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 332.26M | - | 419,795 | 33.98M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 323.65M | -1.34% | 386,200 | - |
| 252 | NGNE | Neurogene Inc. | 320.48M | 1.22% | 116,047 | 925.00K |
| 253 | PALI | Palisade Bio, Inc. | 320.36M | -5.70% | 2,069,317 | - |
| 254 | ALDX | Aldeyra Therapeutics, Inc. | 316.46M | 0.57% | 1,115,820 | - |
| 255 | LRMR | Larimar Therapeutics, Inc. | 314.12M | 0.27% | 1,500,905 | - |
| 256 | EPRX | Eupraxia Pharmaceuticals Inc. | 312.99M | -1.13% | 200,997 | - |
| 257 | RLMD | Relmada Therapeutics, Inc. | 312.40M | -0.93% | 787,708 | - |
| 258 | CTNM | Contineum Therapeutics, Inc. | 312.25M | 3.28% | 197,952 | - |
| 259 | CYBN | Cybin Inc. | 307.91M | 4.75% | 544,588 | - |
| 260 | ALLO | Allogene Therapeutics, Inc. | 305.63M | 0.74% | 2,502,293 | 22.00K |
| 261 | OBIO | Orchestra BioMed Holdings, Inc. | 302.09M | 10.54% | 662,969 | 2.82M |
| 262 | SLN | Silence Therapeutics plc | 299.94M | 0.79% | 196,603 | 25.83M |
| 263 | AVXL | Anavex Life Sciences Corp. | 297.19M | 12.34% | 4,524,781 | - |
| 264 | ACRS | Aclaris Therapeutics, Inc. | 295.78M | -0.73% | 829,319 | 15.74M |
| 265 | VNDA | Vanda Pharmaceuticals Inc. | 295.48M | 2.25% | 455,441 | 212.07M |
| 266 | TARA | Protara Therapeutics, Inc. | 291.72M | 2.58% | 731,181 | - |
| 267 | ACIU | AC Immune SA | 286.94M | -5.84% | 727,392 | 5.48M |
| 268 | MREO | Mereo BioPharma Group plc | 284.85M | - | 1,469,865 | 500.00K |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 276.61M | 5.80% | 213,366 | - |
| 270 | CBIO | Crescent Biopharma, Inc. | 273.69M | -0.36% | 24,021 | - |
| 271 | FENC | Fennec Pharmaceuticals Inc. | 270.50M | 2.59% | 314,514 | 38.79M |
| 272 | OABI | OmniAb, Inc. | 267.76M | 7.51% | 365,830 | 21.09M |
| 273 | FHTX | Foghorn Therapeutics Inc. | 266.92M | 3.51% | 176,245 | 24.52M |
| 274 | ABEO | Abeona Therapeutics Inc. | 264.45M | 6.32% | 1,837,170 | 400.00K |
| 275 | ARMP | Armata Pharmaceuticals, Inc. | 257.94M | 3.50% | 42,894 | 5.05M |
| 276 | IMMP | Immutep Limited | 251.72M | 2.84% | 45,052 | 3.31M |
| 277 | MIST | Milestone Pharmaceuticals Inc. | 250.91M | 4.22% | 2,341,650 | - |
| 278 | PBYI | Puma Biotechnology, Inc. | 249.44M | -0.60% | 587,637 | 212.00M |
| 279 | HUMA | Humacyte, Inc. | 247.20M | 3.13% | 3,064,206 | 1.57M |
| 280 | CADL | Candel Therapeutics, Inc. | 245.40M | -1.32% | 652,818 | - |
| 281 | ACHV | Achieve Life Sciences, Inc. | 244.34M | 15.62% | 1,221,699 | - |
| 282 | ZURA | Zura Bio Limited | 243.84M | 0.27% | 291,457 | - |
| 283 | CCCC | C4 Therapeutics, Inc. | 240.35M | 0.81% | 871,524 | 30.11M |
| 284 | AVIR | Atea Pharmaceuticals, Inc. | 236.33M | 1.51% | 403,919 | - |
| 285 | MDWD | MediWound Ltd. | 233.35M | 0.44% | 83,448 | 20.93M |
| 286 | EDIT | Editas Medicine, Inc. | 233.31M | -4.40% | 1,225,055 | 46.38M |
| 287 | SGMT | Sagimet Biosciences Inc. | 227.00M | 4.65% | 340,425 | - |
| 288 | PRQR | ProQR Therapeutics N.V. | 225.44M | -2.73% | 365,207 | 18.86M |
| 289 | VYGR | Voyager Therapeutics, Inc. | 220.73M | -3.17% | 1,131,613 | 31.32M |
| 290 | BDTX | Black Diamond Therapeutics, Inc. | 220.49M | 0.52% | 877,802 | 70.00M |
| 291 | ETHZ | ETHZilla Corporation | 216.98M | -1.46% | 622,352 | 4.11M |
| 292 | TLSA | Tiziana Life Sciences Ltd | 216.26M | 5.20% | 877,637 | - |
| 293 | CABA | Cabaletta Bio, Inc. | 211.78M | -4.35% | 1,959,507 | - |
| 294 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 210.67M | -0.61% | 223,331 | - |
| 295 | CAPR | Capricor Therapeutics, Inc. | 210.30M | -0.86% | 3,494,205 | 11.13M |
| 296 | SLS | SELLAS Life Sciences Group, Inc. | 205.12M | -7.10% | 3,629,293 | - |
| 297 | TNYA | Tenaya Therapeutics, Inc. | 204.80M | 0.82% | 1,303,754 | - |
| 298 | AARD | Aardvark Therapeutics, Inc. | 203.58M | -1.58% | 90,967 | - |
| 299 | GUTS | Fractyl Health, Inc. | 200.08M | - | 1,778,033 | 3.00K |
| 300 | HRTX | Heron Therapeutics, Inc. | 199.87M | -3.54% | 2,022,691 | 155.10M |
| 301 | GNLX | Genelux Corporation | 199.00M | 3.73% | 170,450 | 8.00K |
| 302 | RANI | Rani Therapeutics Holdings, Inc. | 195.63M | -3.01% | 2,327,167 | 1.20M |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 193.21M | 7.42% | 1,257,655 | 97.60M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 190.35M | -1.48% | 109,562 | 1.09M |
| 305 | SABS | SAB Biotherapeutics, Inc. | 187.09M | -2.24% | 402,725 | 114.70K |
| 306 | VTGN | Vistagen Therapeutics, Inc. | 185.23M | -0.64% | 1,263,816 | 721.00K |
| 307 | IPHA | Innate Pharma S.A. | 178.28M | 2.76% | 17,533 | 14.84M |
| 308 | CRBU | Caribou Biosciences, Inc. | 174.79M | - | 1,074,645 | 9.30M |
| 309 | NTHI | NeOnc Technologies Holdings, Inc. | 172.15M | 20.77% | 207,696 | 59.99K |
| 310 | TNXP | Tonix Pharmaceuticals Holding Corp. | 165.81M | -1.47% | 826,816 | 10.30M |
| 311 | VOR | Vor Biopharma Inc. | 162.47M | -4.78% | 507,052 | - |
| 312 | CAMP | Camp4 Therapeutics Corporation | 158.46M | 1.50% | 65,381 | 3.80M |
| 313 | ELTX | Elicio Therapeutics, Inc. | 156.40M | 3.83% | 118,542 | - |
| 314 | NVCT | Nuvectis Pharma, Inc. | 155.99M | 1.67% | 72,164 | - |
| 315 | CNTB | Connect Biopharma Holdings Limited | 155.41M | -4.47% | 123,539 | 762.00K |
| 316 | CHRS | Coherus Oncology, Inc. | 154.71M | - | 566,544 | 277.73M |
| 317 | MCRB | Seres Therapeutics, Inc. | 153.07M | -0.29% | 92,073 | 351.00K |
| 318 | CDXS | Codexis, Inc. | 151.74M | 5.66% | 660,155 | 52.93M |
| 319 | MOLN | Molecular Partners AG | 149.75M | 5.39% | - | 856.30K |
| 320 | AGEN | Agenus Inc. | 148.96M | 2.10% | 387,012 | 106.83M |
| 321 | CGEN | Compugen Ltd. | 148.72M | - | 197,779 | 6.90M |
| 322 | QNCX | Quince Therapeutics, Inc. | 148.67M | 6.80% | 1,685,583 | - |
| 323 | SAVA | Cassava Sciences, Inc. | 146.86M | 4.83% | 2,006,579 | - |
| 324 | ACTU | Actuate Therapeutics, Inc. | 145.27M | -0.16% | 40,838 | - |
| 325 | IMMX | Immix Biopharma, Inc. | 144.38M | -0.46% | 283,056 | - |
| 326 | PLX | Protalix BioTherapeutics, Inc. | 143.95M | 2.29% | 422,658 | 61.84M |
| 327 | ANIX | Anixa Biosciences, Inc. | 142.20M | -0.69% | 90,462 | - |
| 328 | CRDF | Cardiff Oncology, Inc. | 142.13M | 1.44% | 463,791 | 501.00K |
| 329 | ALEC | Alector, Inc. | 139.71M | - | 820,750 | 69.05M |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 139.68M | -0.36% | 4,294,746 | 32.88M |
| 331 | SRZN | Surrozen, Inc. | 137.23M | 22.21% | 260,815 | 3.60M |
| 332 | MRSN | Mersana Therapeutics, Inc. | 136.99M | 0.05% | 50,237 | 33.18M |
| 333 | IRD | Opus Genetics, Inc. | 136.55M | -1.00% | 305,503 | 14.63M |
| 334 | EXOZ | eXoZymes, Inc. | 134.20M | 3.29% | 1,526 | -700.00 |
| 335 | ACOG | Alpha Cognition Inc. | 132.52M | 1.25% | 20,485 | 7.43M |
| 336 | SPRO | Spero Therapeutics, Inc. | 131.83M | -1.68% | 284,206 | 40.55M |
| 337 | PRLD | Prelude Therapeutics Incorporated | 131.01M | 13.57% | 802,919 | 10.50M |
| 338 | CGTX | Cognition Therapeutics, Inc. | 128.88M | -4.58% | 713,950 | - |
| 339 | NKTX | Nkarta, Inc. | 128.56M | 1.12% | 408,025 | - |
| 340 | ANVS | Annovis Bio, Inc. | 127.74M | 17.85% | 2,367,455 | - |
| 341 | STTK | Shattuck Labs, Inc. | 127.19M | -2.43% | 56,317 | 1.00M |
| 342 | COYA | Coya Therapeutics, Inc. | 126.80M | 0.17% | 102,976 | 3.99M |
| 343 | ELDN | Eledon Pharmaceuticals, Inc. | 125.50M | 3.73% | 1,567,648 | - |
| 344 | INO | Inovio Pharmaceuticals, Inc. | 124.35M | - | 623,152 | 182.34K |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 122.93M | 3.62% | 253,624 | - |
| 346 | CLYM | Climb Bio, Inc. | 122.73M | 2.27% | 297,604 | - |
| 347 | FATE | Fate Therapeutics, Inc. | 122.27M | -1.85% | 939,027 | 7.14M |
| 348 | CNTX | Context Therapeutics Inc. | 119.38M | -2.61% | 377,952 | - |
| 349 | NBY | NovaBay Pharmaceuticals, Inc. | 118.46M | 3.31% | 61,576 | 10.30M |
| 350 | IKT | Inhibikase Therapeutics, Inc. | 118.03M | 1.29% | 353,547 | 1.00 |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 117.51M | 14.12% | 374,070 | - |
| 352 | DTIL | Precision BioSciences, Inc. | 117.47M | -4.31% | 126,778 | 698.00K |
| 353 | KLRS | Kalaris Therapeutics, Inc. | 117.08M | -2.95% | 87,335 | - |
| 354 | GLSI | Greenwich LifeSciences, Inc. | 116.38M | 7.01% | 48,589 | - |
| 355 | ORMP | Oramed Pharmaceuticals Inc. | 114.63M | 11.20% | 513,121 | 2.00M |
| 356 | ENTX | Entera Bio Ltd. | 114.18M | 4.84% | 225,588 | 124.00K |
| 357 | SPRB | Spruce Biosciences, Inc. | 111.93M | -2.27% | 90,301 | 697.00K |
| 358 | SLGL | Sol-Gel Technologies Ltd. | 109.75M | -5.66% | 12,083 | 18.97M |
| 359 | ONCY | Oncolytics Biotech Inc. | 109.33M | - | 452,586 | - |
| 360 | SEER | Seer, Inc. | 107.95M | -0.77% | 210,088 | 16.38M |
| 361 | OVID | Ovid Therapeutics Inc. | 106.82M | 0.67% | 1,861,116 | 6.61M |
| 362 | GANX | Gain Therapeutics, Inc. | 105.40M | 3.18% | 447,002 | - |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 105.05M | 3.85% | 58,207 | 151.93M |
| 364 | ZNTL | Zentalis Pharmaceuticals, Inc. | 104.04M | 3.60% | 388,399 | 26.87M |
| 365 | ANEB | Anebulo Pharmaceuticals, Inc. | 102.30M | 5.24% | 4,266 | - |
| 366 | WHWK | Whitehawk Therapeutics, Inc. | 101.33M | -2.71% | 184,153 | 14.38M |
| 367 | ATOS | Atossa Therapeutics, Inc. | 99.59M | 2.58% | 237,111 | - |
| 368 | HURA | TuHURA Biosciences, Inc. | 99.44M | 2.65% | 141,172 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 97.17M | -5.71% | 82,767 | - |
| 370 | ACET | Adicet Bio, Inc. | 97.00M | -2.01% | 1,419,943 | - |
| 371 | PLRX | Pliant Therapeutics, Inc. | 96.48M | - | 522,617 | - |
| 372 | VANI | Vivani Medical, Inc. | 96.30M | - | 166,710 | - |
| 373 | COEP | Coeptis Therapeutics Holdings, Inc. | 94.20M | -0.06% | 13,609 | 501.00K |
| 374 | ADAG | Adagene Inc. | 93.79M | 4.74% | 255,752 | 103.20K |
| 375 | KPTI | Karyopharm Therapeutics Inc. | 92.93M | -1.98% | 118,422 | 142.53M |
| 376 | MGNX | MacroGenics, Inc. | 91.72M | 2.11% | 754,793 | 127.63M |
| 377 | RPTX | Repare Therapeutics Inc. | 91.13M | - | 488,303 | 11.87M |
| 378 | ADVM | Adverum Biotechnologies, Inc. | 90.30M | -0.73% | 560,444 | 1.00M |
| 379 | CSBR | Champions Oncology, Inc. | 90.18M | - | 4,230 | 56.88M |
| 380 | CRVO | CervoMed Inc. | 89.06M | 3.83% | 70,325 | 6.16M |
| 381 | THAR | Tharimmune, Inc. | 87.96M | -1.18% | 99,310 | - |
| 382 | TVGN | Tevogen Bio Holdings Inc. | 87.17M | 3.47% | 206,626 | - |
| 383 | VXRT | Vaxart, Inc. | 86.46M | -0.19% | - | 148.20M |
| 384 | IMUX | Immunic, Inc. | 84.98M | 2.39% | 690,719 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 83.49M | 5.49% | 218,331 | 62.30M |
| 386 | PTHS | Pelthos Therapeutics Inc. | 83.00M | -1.53% | 26,497 | 7.41M |
| 387 | HYFT | MindWalk Holdings Corp. | 82.62M | 1.70% | 169,592 | 18.21M |
| 388 | ARTV | Artiva Biotherapeutics, Inc. | 82.10M | 1.06% | 37,935 | 251.00K |
| 389 | BYSI | BeyondSpring Inc. | 81.42M | 5.88% | 18,012 | 1.88M |
| 390 | IFRX | InflaRx N.V. | 79.94M | -1.67% | 527,796 | 73.73K |
| 391 | ALXO | ALX Oncology Holdings Inc. | 78.62M | -3.97% | 85,989 | - |
| 392 | TIL | Instil Bio, Inc. | 77.86M | -2.96% | 39,699 | - |
| 393 | IMA | ImageneBio, Inc. | 77.22M | 4.92% | 77,953 | 800.00K |
| 394 | PSTV | Plus Therapeutics, Inc. | 77.07M | -2.50% | 2,611,111 | 5.26M |
| 395 | ATYR | aTyr Pharma, Inc. | 75.19M | -1.31% | 2,100,669 | 190.00K |
| 396 | OKYO | OKYO Pharma Limited | 75.00M | -4.13% | 160,669 | - |
| 397 | MNOV | MediciNova, Inc. | 74.55M | 7.04% | 107,210 | 257.92K |
| 398 | STRO | Sutro Biopharma, Inc. | 73.22M | -1.71% | 475,080 | 105.65M |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 73.21M | -1.69% | 378,081 | - |
| 400 | BMEA | Biomea Fusion, Inc. | 72.82M | 1.98% | 1,052,650 | - |
| 401 | CBUS | Cibus, Inc. | 72.20M | 4.72% | 73,000 | 3.79M |
| 402 | XBIT | XBiotech Inc. | 71.65M | 3.07% | 58,333 | - |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 71.30M | -0.74% | 239,285 | - |
| 404 | OTLK | Outlook Therapeutics, Inc. | 71.07M | -11.11% | 5,407,336 | 1.51M |
| 405 | ATHE | Alterity Therapeutics Limited | 70.18M | -1.15% | 12,518 | 3.57M |
| 406 | ESLA | Estrella Immunopharma, Inc. | 68.73M | 0.55% | 97,545 | - |
| 407 | LITS | Lite Strategy, Inc. | 67.69M | 0.55% | 215,322 | - |
| 408 | OSTX | OS Therapies Incorporated | 63.39M | 4.65% | 339,256 | - |
| 409 | MGX | Metagenomi, Inc. | 62.70M | 5.03% | 280,492 | 30.91M |
| 410 | PYPD | PolyPid Ltd. | 61.30M | 1.80% | 81,827 | - |
| 411 | NRXP | NRx Pharmaceuticals, Inc. | 61.25M | -2.68% | 135,191 | 242.00K |
| 412 | ABVC | ABVC BioPharma, Inc. | 60.58M | 1.58% | 53,626 | 797.92K |
| 413 | ALGS | Aligos Therapeutics, Inc. | 59.51M | 1.58% | 92,073 | 2.65M |
| 414 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 58.27M | -4.16% | 2,323,928 | - |
| 415 | NTRB | Nutriband Inc. | 57.56M | 2.35% | 20,749 | 2.58M |
| 416 | CALC | CalciMedica, Inc. | 56.92M | -5.73% | 124,224 | - |
| 417 | EQ | Equillium, Inc. | 56.90M | -1.29% | 254,432 | 4.39M |
| 418 | CELU | Celularity Inc. | 55.81M | 2.34% | 184,504 | 40.58M |
| 419 | TCRX | TScan Therapeutics, Inc. | 55.53M | -1.18% | 634,667 | 8.42M |
| 420 | SNTI | Senti Biosciences, Inc. | 54.68M | -0.48% | 43,507 | - |
| 421 | KRRO | Korro Bio, Inc. | 53.96M | -2.88% | 360,423 | 7.37M |
| 422 | CVM | CEL-SCI Corporation | 53.64M | 2.76% | 34,518 | - |
| 423 | IOBT | IO Biotech, Inc. | 52.32M | -7.84% | 1,008,886 | - |
| 424 | ANL | Adlai Nortye Ltd. | 51.29M | -1.42% | 7,529 | 1.94M |
| 425 | INKT | MiNK Therapeutics, Inc. | 51.21M | -1.00% | 18,007 | - |
| 426 | JSPR | Jasper Therapeutics, Inc. | 48.97M | 1.74% | 592,535 | - |
| 427 | VRCA | Verrica Pharmaceuticals Inc. | 48.59M | 8.47% | 269,600 | 30.83M |
| 428 | BCAB | BioAtla, Inc. | 48.53M | -3.70% | 1,669,281 | 11.00M |
| 429 | CUE | Cue Biopharma, Inc. | 47.94M | 3.17% | 123,325 | 7.10M |
| 430 | NXTC | NextCure, Inc. | 47.27M | -1.13% | 127,626 | - |
| 431 | IPSC | Century Therapeutics, Inc. | 46.45M | 2.31% | 1,106,968 | 113.34M |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.99M | 1.13% | 152,667 | - |
| 433 | IBO | Impact BioMedical Inc. | 45.72M | 1.63% | 70,594 | 25.00K |
| 434 | GRCE | Grace Therapeutics, Inc. | 45.21M | 2.89% | 52,458 | - |
| 435 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | 3.15% | 393,451 | - |
| 436 | GNTA | Genenta Science S.p.A. | 44.99M | 7.87% | 84,110 | - |
| 437 | EVAX | Evaxion A/S | 44.83M | 0.93% | 42,457 | 7.65M |
| 438 | HOWL | Werewolf Therapeutics, Inc. | 44.19M | -6.80% | 461,672 | 1.14M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 43.67M | 2.19% | 53,495 | 90.00K |
| 440 | LTRN | Lantern Pharma Inc. | 42.84M | 13.65% | 108,352 | - |
| 441 | ICCC | ImmuCell Corporation | 42.33M | -0.85% | 13,146 | 27.77M |
| 442 | BTAI | BioXcel Therapeutics, Inc. | 41.77M | -2.05% | 572,291 | 752.00K |
| 443 | SER | Serina Therapeutics, Inc. | 41.70M | 4.27% | 16,229 | 116.00K |
| 444 | SKYE | Skye Bioscience, Inc. | 41.03M | -1.54% | 136,847 | - |
| 445 | PDSB | PDS Biotechnology Corporation | 40.80M | -1.52% | 235,401 | - |
| 446 | JUNS | Jupiter Neurosciences, Inc. | 40.62M | 0.85% | 29,280 | - |
| 447 | INMB | INmune Bio, Inc. | 40.41M | 2.70% | 254,409 | 50.00K |
| 448 | XLO | Xilio Therapeutics, Inc. | 39.63M | 0.33% | 283,630 | 31.80M |
| 449 | RNTX | Rein Therapeutics Inc. | 38.38M | -2.67% | 250,496 | - |
| 450 | VERU | Veru Inc. | 38.36M | 2.14% | 111,733 | 16.89M |
| 451 | RADX | Radiopharm Theranostics Limited | 37.68M | 2.17% | 44,158 | 8.20M |
| 452 | OKUR | OnKure Therapeutics, Inc. | 37.66M | 1.09% | 32,153 | - |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 36.49M | -0.77% | 96,030 | - |
| 454 | MURA | Mural Oncology plc | 36.26M | 0.14% | 48,909 | - |
| 455 | APLT | Applied Therapeutics, Inc. | 35.95M | -3.56% | 5,304,099 | 1.00M |
| 456 | MAIA | MAIA Biotechnology, Inc. | 35.92M | -1.93% | 154,621 | - |
| 457 | KLTO | Klotho Neurosciences, Inc. | 35.80M | -0.68% | 685,762 | - |
| 458 | GBIO | Generation Bio Co. | 35.78M | 2.51% | 55,518 | 15.27M |
| 459 | APLM | Apollomics, Inc. | 34.64M | -5.00% | 8,936 | 198.00K |
| 460 | FGEN | FibroGen, Inc. | 34.63M | -0.23% | 39,505 | 8.30M |
| 461 | PLUR | Pluri Inc. | 34.61M | 3.31% | 16,674 | 1.33M |
| 462 | DYAI | Dyadic International, Inc. | 34.50M | 4.77% | 355,118 | 3.34M |
| 463 | RNXT | RenovoRx, Inc. | 31.72M | 10.16% | 236,997 | 928.00K |
| 464 | QNTM | Quantum BioPharma Ltd. | 30.57M | 29.68% | 182,635 | - |
| 465 | ANTX | AN2 Therapeutics, Inc. | 30.14M | 0.92% | 20,904 | - |
| 466 | IGC | IGC Pharma, Inc. | 29.51M | -0.38% | 372,610 | 1.11M |
| 467 | BRNS | Barinthus Biotherapeutics plc | 29.03M | 0.06% | 28,296 | 14.97M |
| 468 | HYPD | Hyperion DeFi, Inc. | 29.01M | -0.98% | 217,523 | 345.32K |
| 469 | PASG | Passage Bio, Inc. | 28.55M | 4.94% | 34,720 | - |
| 470 | CLGN | CollPlant Biotechnologies Ltd. | 28.48M | 0.90% | 27,851 | 2.40M |
| 471 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 28.40M | -14.23% | 661,740 | 1.00M |
| 472 | NRXS | NeurAxis, Inc. | 28.23M | 2.71% | 91,102 | 3.36M |
| 473 | RLYB | Rallybio Corporation | 27.42M | 2.14% | 106,777 | 674.00K |
| 474 | NERV | Minerva Neurosciences, Inc. | 26.37M | -0.26% | 29,521 | - |
| 475 | IBIO | iBio, Inc. | 26.31M | 5.41% | 706,752 | 500.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 26.05M | -1.89% | 349,339 | - |
| 477 | LNAI | Lunai Bioworks Inc. | 25.31M | -14.96% | 46,624,161 | - |
| 478 | DARE | Daré Bioscience, Inc. | 25.29M | -1.12% | 33,557 | -57.13K |
| 479 | QTTB | Q32 Bio Inc. | 24.98M | -0.49% | 24,556 | - |
| 480 | CING | Cingulate Inc. | 24.93M | 4.53% | 139,898 | - |
| 481 | BOLD | Boundless Bio, Inc. | 24.85M | - | 116,404 | - |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 24.52M | 2.93% | 32,157 | 15.65M |
| 483 | XCUR | Exicure, Inc. | 24.35M | -7.28% | 45,469 | 500.00K |
| 484 | LEXX | Lexaria Bioscience Corp. | 24.02M | 1.89% | 29,945 | 615.92K |
| 485 | LIMN | Liminatus Pharma, Inc. | 23.95M | 5.02% | 157,056 | - |
| 486 | ENLV | Enlivex Therapeutics Ltd. | 23.81M | -3.92% | 5,438,077 | - |
| 487 | INTS | Intensity Therapeutics, Inc. | 23.76M | -6.10% | 2,107,773 | - |
| 488 | KZIA | Kazia Therapeutics Limited | 23.46M | 51.36% | 1,442,815 | 1.20M |
| 489 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.33M | -8.50% | 412,194 | - |
| 490 | CASI | CASI Pharmaceuticals, Inc. | 23.22M | -5.44% | 24,318 | 26.85M |
| 491 | ITRM | Iterum Therapeutics plc | 23.14M | 4.36% | 644,224 | 390.00K |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 22.54M | 7.02% | 778,317 | - |
| 493 | PTN | Palatin Technologies, Inc. | 22.39M | -7.00% | 91,164 | 8.85M |
| 494 | GLTO | Galecto, Inc. | 22.01M | 1.66% | 40,263 | - |
| 495 | GDTC | CytoMed Therapeutics Limited | 21.93M | -0.52% | 10,440 | 573.19K |
| 496 | NNVC | NanoViricides, Inc. | 21.06M | -5.65% | 206,442 | - |
| 497 | TRAW | Traws Pharma, Inc. | 21.02M | 8.23% | 167,857 | 2.85M |
| 498 | OSRH | OSR Holdings, Inc. | 20.96M | 25.67% | 39,683,177 | -90.52K |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 20.59M | -1.20% | 34,831 | - |
| 500 | APVO | Aptevo Therapeutics Inc. | 20.22M | 1.69% | 548,268 | - |
| 501 | SYBX | Synlogic, Inc. | 19.54M | 1.83% | 3,029 | 8.00K |
| 502 | ABP | Abpro Holdings, Inc. | 18.72M | -0.29% | 8,684 | 183.00K |
| 503 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.71M | 13.83% | 105,393 | - |
| 504 | BCTX | BriaCell Therapeutics Corp. | 18.62M | 13.53% | 60,403 | - |
| 505 | MRKR | Marker Therapeutics, Inc. | 18.34M | -2.65% | 253,222 | 4.69M |
| 506 | MBRX | Moleculin Biotech, Inc. | 18.28M | -1.91% | 979,192 | - |
| 507 | LSTA | Lisata Therapeutics, Inc. | 18.17M | 5.10% | 19,899 | 1.07M |
| 508 | LPCN | Lipocine Inc. | 18.15M | 0.62% | 41,572 | 4.32M |
| 509 | HOTH | Hoth Therapeutics, Inc. | 18.15M | 2.63% | 117,257 | - |
| 510 | ATHA | Athira Pharma, Inc. | 17.71M | 1.70% | 9,739 | - |
| 511 | MTVA | MetaVia Inc. | 17.27M | -4.78% | 62,004 | - |
| 512 | ALLR | Allarity Therapeutics, Inc. | 17.14M | 0.85% | 74,222 | - |
| 513 | PMN | ProMIS Neurosciences, Inc. | 17.06M | -2.79% | 651,662 | - |
| 514 | PULM | Pulmatrix, Inc. | 16.29M | -0.89% | 6,941 | 3.00K |
| 515 | NCNA | NuCana plc | 16.02M | 1.32% | 73,087 | - |
| 516 | NCEL | NewcelX Ltd. | 15.95M | 4.48% | 51,798 | - |
| 517 | AKTX | Akari Therapeutics, Plc | 15.94M | 0.88% | 77,373 | - |
| 518 | CANF | Can-Fite BioPharma Ltd. | 15.62M | 2.75% | 1,359,861 | 560.00K |
| 519 | KAPA | Kairos Pharma, Ltd. | 15.28M | 0.82% | 54,363 | - |
| 520 | BCDA | BioCardia, Inc. | 15.18M | 3.62% | 74,100 | 3.00K |
| 521 | CMMB | Chemomab Therapeutics Ltd. | 14.90M | 0.41% | 37,236 | - |
| 522 | DWTX | Dogwood Therapeutics, Inc. | 14.75M | 3.54% | 26,323 | - |
| 523 | CRIS | Curis, Inc. | 14.61M | - | 64,671 | 11.65M |
| 524 | BLRX | BioLineRx Ltd. | 14.33M | 1.43% | 83,253 | 12.74M |
| 525 | SNGX | Soligenix, Inc. | 14.22M | -1.40% | 223,188 | 2.34K |
| 526 | TPST | Tempest Therapeutics, Inc. | 14.21M | -23.26% | 692,599 | - |
| 527 | FBLG | FibroBiologics, Inc. | 13.79M | 3.08% | 2,985,519 | - |
| 528 | PCSA | Processa Pharmaceuticals, Inc. | 13.72M | -7.77% | 2,095,880 | - |
| 529 | CLRB | Cellectar Biosciences, Inc. | 13.02M | 5.86% | 29,981 | - |
| 530 | COCP | Cocrystal Pharma, Inc. | 12.98M | -1.80% | 81,466 | - |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 12.92M | 3.45% | 364,490 | - |
| 532 | LGVN | Longeveron Inc. | 12.91M | -3.22% | 203,254 | 1.44M |
| 533 | VYNE | VYNE Therapeutics Inc. | 12.76M | 4.99% | 781,863 | 524.00K |
| 534 | AIXC | AIxCrypto Holdings, Inc. | 12.59M | -6.87% | 77,923 | - |
| 535 | IMRN | Immuron Limited | 11.83M | 4.19% | 29,545 | 4.78M |
| 536 | EDSA | Edesa Biotech, Inc. | 11.82M | -3.17% | 36,296 | - |
| 537 | IMNN | Imunon, Inc. | 11.67M | 1.33% | 11,360 | - |
| 538 | ICU | SeaStar Medical Holding Corporation | 11.46M | 4.19% | 21,979,538 | 881.00K |
| 539 | GOVX | GeoVax Labs, Inc. | 11.27M | -0.16% | 343,862 | 3.35M |
| 540 | PPCB | Propanc Biopharma, Inc. | 10.98M | 1.42% | 27,994 | - |
| 541 | ASBP | Aspire Biopharma Holdings, Inc. | 10.88M | 1.20% | 10,631,122 | 1.94K |
| 542 | SNSE | Sensei Biotherapeutics, Inc. | 10.85M | -4.23% | 19,058 | - |
| 543 | ERNA | Ernexa Therapeutics Inc. | 10.60M | 4.65% | 23,276 | 1,000.00 |
| 544 | APM | Aptorum Group Limited | 10.34M | -3.05% | 56,942 | - |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 10.24M | 4.48% | 61,014 | - |
| 546 | BIVI | BioVie Inc. | 10.18M | - | 24,854 | - |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 10.13M | 0.74% | 77,230 | 6.00K |
| 548 | EVGN | Evogene Ltd. | 9.96M | -4.35% | 47,214 | 8.02M |
| 549 | BRTX | BioRestorative Therapies, Inc. | 9.85M | 5.71% | 14,558 | 383.40K |
| 550 | AEON | AEON Biopharma, Inc. | 9.72M | 1.20% | 56,880 | - |
| 551 | BOLT | Bolt Biotherapeutics, Inc. | 9.71M | 1.40% | 9,918 | 5.20M |
| 552 | ENTO | Entero Therapeutics, Inc. | 9.38M | -3.46% | 39,703 | - |
| 553 | PHGE | BiomX Inc. | 8.82M | 5.28% | 123,564 | - |
| 554 | INAB | IN8bio, Inc. | 8.76M | -3.57% | 37,316 | - |
| 555 | MBIO | Mustang Bio, Inc. | 8.61M | - | 60,320 | - |
| 556 | RNAZ | TransCode Therapeutics, Inc. | 8.43M | 1.55% | 6,115 | - |
| 557 | ALZN | Alzamend Neuro, Inc. | 8.14M | 2.88% | 30,950 | - |
| 558 | ACXP | Acurx Pharmaceuticals, Inc. | 8.07M | -6.52% | 43,827 | - |
| 559 | TOVX | Theriva Biologics, Inc. | 8.06M | 3.42% | 1,552,224 | - |
| 560 | GTBP | GT Biopharma, Inc. | 7.95M | -1.79% | 521,326 | - |
| 561 | TCRT | Alaunos Therapeutics, Inc. | 7.70M | 2.68% | 47,859 | 6.00K |
| 562 | APRE | Aprea Therapeutics, Inc. | 7.64M | 3.42% | 12,286 | 488.24K |
| 563 | XTLB | XTL Biopharmaceuticals Ltd. | 7.53M | -6.40% | 26,413 | 451.00K |
| 564 | ADXN | Addex Therapeutics Ltd | 7.46M | 5.48% | - | 210.35K |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 7.36M | -5.25% | 692,234 | - |
| 566 | PLRZ | Polyrizon Ltd. | 6.90M | -14.28% | 584,895 | - |
| 567 | GRI | GRI Bio, Inc. | 6.73M | -1.44% | 89,631 | - |
| 568 | BGMS | Bio Green Med Solution, Inc. | 6.62M | -4.26% | 20,188 | 81.00K |
| 569 | PPBT | Purple Biotech Ltd | 6.61M | -2.62% | 213,950 | - |
| 570 | KPRX | Kiora Pharmaceuticals, Inc. | 6.60M | -1.10% | 50,549 | 20.00K |
| 571 | PMCB | PharmaCyte Biotech, Inc. | 6.05M | 36.92% | 57,907,388 | - |
| 572 | ENSC | Ensysce Biosciences, Inc. | 6.02M | 1.80% | 25,699 | 4.49M |
| 573 | XBIO | Xenetic Biosciences, Inc. | 5.77M | 2.44% | 19,245 | 2.86M |
| 574 | SILO | Silo Pharma, Inc. | 5.75M | 1.41% | 85,586 | 72.10K |
| 575 | VIVS | VivoSim Labs, Inc. | 5.71M | -2.67% | 108,678 | 140.00K |
| 576 | CYCN | Cyclerion Therapeutics, Inc. | 5.60M | -1.34% | 52,829 | 2.86M |
| 577 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.35M | -7.86% | 18,581 | 15.78K |
| 578 | KALA | KALA BIO, Inc. | 5.24M | 3.45% | 3,043,803 | - |
| 579 | HCWB | HCW Biologics Inc. | 5.19M | -11.52% | 207,211 | 422.03K |
| 580 | SLRX | Salarius Pharmaceuticals, Inc. | 5.17M | -6.61% | 400,514 | - |
| 581 | LYRA | Lyra Therapeutics, Inc. | 5.11M | -5.57% | 75,588 | 600.00K |
| 582 | REVB | Revelation Biosciences, Inc. | 4.97M | -1.33% | 66,327 | - |
| 583 | GNPX | Genprex, Inc. | 4.81M | 5.36% | 126,715 | - |
| 584 | MTNB | Matinas BioPharma Holdings, Inc. | 4.64M | -8.28% | 26,788 | - |
| 585 | JAGX | Jaguar Health, Inc. | 4.63M | -2.36% | 203,197 | 11.79M |
| 586 | GLMD | Galmed Pharmaceuticals Ltd. | 4.50M | -3.20% | 133,992 | - |
| 587 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.36M | 1.98% | 16,736 | 1.36M |
| 588 | XRTX | XORTX Therapeutics Inc. | 4.34M | 2.04% | 88,239 | - |
| 589 | PTIX | Protagenic Therapeutics, Inc. | 4.27M | -1.76% | 89,505 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 4.19M | -1.17% | 5,094 | - |
| 591 | SPRC | SciSparc Ltd. | 3.96M | -1.61% | 13,505 | 1.31M |
| 592 | OGEN | Oragenics, Inc. | 3.92M | -0.52% | 39,531 | - |
| 593 | ELAB | PMGC Holdings Inc. | 3.90M | 8.94% | 26,824 | -241.53K |
| 594 | KTTA | Pasithea Therapeutics Corp. | 3.63M | 14.78% | 8,370,395 | - |
| 595 | ENVB | Enveric Biosciences, Inc. | 3.55M | 3.13% | 9,679 | - |
| 596 | ONCO | Onconetix, Inc. | 3.51M | -4.26% | 16,877 | 1.22M |
| 597 | ARTL | Artelo Biosciences, Inc. | 3.49M | -2.81% | 14,309 | - |
| 598 | INDP | Indaptus Therapeutics, Inc. | 3.28M | -1.88% | 33,536 | - |
| 599 | AZTR | Azitra, Inc. | 3.16M | -4.08% | 247,170 | 7.50K |
| 600 | CLSD | Clearside Biomedical, Inc. | 3.14M | -33.33% | 1,254,267 | 3.33M |
| 601 | DRMA | Dermata Therapeutics, Inc. | 3.04M | - | 30,509 | - |
| 602 | CDT | CDT Equity Inc. | 3.00M | 5.14% | 20,788 | - |
| 603 | PBM | Psyence Biomedical Ltd. | 3.00M | 5.96% | 578,488 | - |
| 604 | SCNI | Scinai Immunotherapeutics Ltd. | 2.94M | 3.23% | 8,743 | 1.15M |
| 605 | BDRX | Biodexa Pharmaceuticals Plc | 2.42M | -9.57% | 88,902 | 104.90K |
| 606 | VRAX | Virax Biolabs Group Limited | 1.76M | 6.44% | 176,791 | 6.33K |
| 607 | MLEC | Moolec Science SA | 1.68M | -5.42% | 118,478 | 7.83M |
| 608 | ADTX | Aditxt, Inc. | 1.47M | -26.33% | 291,501 | 5.95K |
| 609 | SLXN | Silexion Therapeutics Corp | 1.35M | 7.62% | 130,964 | - |
| 610 | CMND | Clearmind Medicine Inc. | 874.63K | -19.40% | 57,036,928 | - |